without_worries

Invivo Therapeutics - Bullish divergence + volume

Long
NASDAQ:NVIV   None
*investment opportunity*

Following a massive 100% correction in price action since 2015 and two oversold conditions (orange columns) the above 10-day chart is now indicating a ‘great buy’ opportunity.

The opportunity is highlighted by regular bullish divergence between price action and the oscillators. Most notably the Money Flow Index (MFI) and Stochastic RSI have been diverging with price action since the beginning of the year. In addition to this there is a significant volume flowing in.
Trade active:
50% in only 25-days - amazing. Not expecting a pullback in the current rally until the month of March.
Trade active:
Make that 100% - choo choo.
Trade active:
Good re-accumulation / dollar cost average point as price action returns to support
Trade active
Trade active:
Text did not display above for some reason - old computer / operator ;)

Price action has corrected to the golden ratio, hence the 'trade active' signal.

Comment:
For whatever reason volume continues to increase in this small market cap. Additionally the regular bullish divergence grows with more and more depth. Higher lows on stochastic RSI versus lower lows in price action.

Be patient, one day price action will likely be multiples of current trading price action.

Trade active:
A first. What first? The first time I've seen this many oscillators printing bullish divergence on the 10-day chart.

On the 10-day chart below 9 oscillators are printing bullish divergence with price action. The higher lows in Stochastic RSI continue to print since 2019. One day it will just pop. Remember the market capital is a tiny $7.5m.

Trade active:
There was a reversal share split yesterday. Changes nothing. The monthly continues to look incredibly bullish.

Trade active
Comment:
Resistance breakout on the 2-week chart with a 75% move today. No idea why.


BTC
bc1q2eckdzh0q8vsd7swcc8et6ze7s99khhxyl7zwy

Weblink: www.patreon.com/withoutworries

Allow 3-6 months on ideas. Not investment advice. DYOR
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.